| abstract |
The present invention pertains to an anti-SARS-CoV-2 drug containing a compound represented by formula (I): [in the formula, one of R a and R c is a substituted phenylamino group, the other of R a and R c is a hydrogen atom, a deuterium atom, or a C 1-10 -alkyl group, R b , R f , and R g are the same or different and are hydrogen atoms or deuterium atoms, R d is a hydrogen atom, a deuterium atom, or a chlorine atom, and R e is a hydrogen atom, a deuterium atom, or a halogen atom] or a salt thereof, or a solvate of these. |